SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001461993-19-000031
Filing Date
2019-06-12
Accepted
2019-06-12 13:37:15
Documents
1
Period of Report
2019-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_156036102095305.html 4  
1 FORM 4 wf-form4_156036102095305.xml 4 3968
  Complete submission text file 0001461993-19-000031.txt   5526
Mailing Address C/O NXSTAGE MEDICAL INC. (NXTM) 439 SOUTH UNION STREET, 5TH FLOOR LAWRENCE MA 01843
Business Address
GILL DAVID N (Reporting) CIK: 0001106519 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35405 | Film No.: 19893330

Mailing Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963
Business Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963 908 617-1309
MELINTA THERAPEUTICS, INC. /NEW/ (Issuer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations